tiprankstipranks
Oculis Holding Ag (OCS)
NASDAQ:OCS
US Market
OCS
Oculis Holding
RESEARCH TOOLSreports
Want to see OCS full AI Analyst Report?

Oculis Holding (OCS) Stock Forecast & Price Target

198 Followers
See the Price Targets and Ratings of:

OCS Analyst Ratings

Strong Buy
10Ratings
Strong Buy
10 Buy
0 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Oculis
Holding
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

OCS Stock 12 Month Forecast

Average Price Target

$38.30
▲(39.48% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Oculis Holding in the last 3 months. The average price target is $38.30 with a high forecast of $53.00 and a low forecast of $23.00. The average price target represents a 39.48% change from the last price of $27.46.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"13":"$13","54":"$54","23.25":"$23.3","33.5":"$33.5","43.75":"$43.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":53,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$53.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":38.3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$38.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$23.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[13,23.25,33.5,43.75,54],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.51,17.470769230769232,20.431538461538462,23.392307692307693,26.353076923076923,29.313846153846153,32.27461538461539,35.23538461538462,38.19615384615385,41.15692307692308,44.11769230769231,47.07846153846154,50.03923076923077,{"y":53,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.51,16.34,18.169999999999998,20,21.83,23.659999999999997,25.49,27.32,29.15,30.979999999999997,32.809999999999995,34.64,36.47,{"y":38.3,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.51,15.163076923076924,15.816153846153846,16.46923076923077,17.122307692307693,17.775384615384617,18.428461538461537,19.08153846153846,19.734615384615385,20.38769230769231,21.04076923076923,21.693846153846152,22.346923076923076,{"y":23,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":19.22,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.96,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.7,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.15,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.4,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.28,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.97,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.03,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.61,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.03,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.48,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.51,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$53.00Average Price Target$38.30Lowest Price Target$23.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on OCS
Tessa Romero
J.P. Morgan
J.P. Morgan
$42→$23
Buy
-16.24%
Downside
Reiterated
06/03/26
J.P. Morgan Reaffirms Their Buy Rating on Oculis Holding (OCS)
Leerink Partners Analyst forecast on OCS
Unknown Analyst
Leerink Partners
Not Ranked
Leerink Partners
$50→$40
Buy
45.67%
Upside
Reiterated
06/02/26
Oculis Holding (OCS) Gets a Buy from Leerink Partners
Guggenheim Analyst forecast on OCS
Yatin Suneja
Guggenheim
Guggenheim
$75→$45
Buy
63.87%
Upside
Reiterated
06/01/26
Oculis price target lowered to $45 from $75 at GuggenheimOculis price target lowered to $45 from $75 at Guggenheim
Bank of America Securities Analyst forecast on OCS
Jason Gerberry
Bank of America Securities
Bank of America Securities
$44→$35
Buy
27.46%
Upside
Reiterated
06/01/26
Oculis price target lowered to $35 from $44 at BofAOculis price target lowered to $35 from $44 at BofA
Stifel Nicolaus Analyst forecast on OCS
Annabel Samimy
Stifel Nicolaus
Stifel Nicolaus
$50→$40
Buy
45.67%
Upside
Reiterated
06/01/26
Oculis price target lowered to $40 from $50 at StifelOculis price target lowered to $40 from $50 at Stifel
Needham Analyst forecast on OCS
Serge Belanger
Needham
Needham
$46→$38
Buy
38.38%
Upside
Reiterated
06/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT), Oculis Holding (NASDAQ: OCS) and Cogent Biosciences (NASDAQ: COGT)
LifeSci Capital Analyst forecast on OCS
Patrick Dolezal
LifeSci Capital
LifeSci Capital
$65→$45
Buy
63.87%
Upside
Reiterated
06/01/26
Oculis Maintained at Buy as Analyst Lowers Price Target to $45, Refocuses on Optic Neuritis Opportunity
H.C. Wainwright Analyst forecast on OCS
Yi Chen
H.C. Wainwright
H.C. Wainwright
$47→$26
Buy
-5.32%
Downside
Reiterated
06/01/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Robert W. Baird Analyst forecast on OCS
Colleen M. Kusy
Robert W. Baird
Robert W. Baird
$49→$38
Buy
38.38%
Upside
Reiterated
06/01/26
Oculis price target lowered to $38 from $49 at BairdOculis price target lowered to $38 from $49 at Baird
Chardan Capital Analyst forecast on OCS
Daniil Gataulin
Chardan Capital
Chardan Capital
$53
Buy
93.01%
Upside
Reiterated
05/12/26
Oculis Holding (OCS) Gets a Buy from Chardan Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on OCS
Tessa Romero
J.P. Morgan
J.P. Morgan
$42→$23
Buy
-16.24%
Downside
Reiterated
06/03/26
J.P. Morgan Reaffirms Their Buy Rating on Oculis Holding (OCS)
Leerink Partners Analyst forecast on OCS
Unknown Analyst
Leerink Partners
Not Ranked
Leerink Partners
$50→$40
Buy
45.67%
Upside
Reiterated
06/02/26
Oculis Holding (OCS) Gets a Buy from Leerink Partners
Guggenheim Analyst forecast on OCS
Yatin Suneja
Guggenheim
Guggenheim
$75→$45
Buy
63.87%
Upside
Reiterated
06/01/26
Oculis price target lowered to $45 from $75 at GuggenheimOculis price target lowered to $45 from $75 at Guggenheim
Bank of America Securities Analyst forecast on OCS
Jason Gerberry
Bank of America Securities
Bank of America Securities
$44→$35
Buy
27.46%
Upside
Reiterated
06/01/26
Oculis price target lowered to $35 from $44 at BofAOculis price target lowered to $35 from $44 at BofA
Stifel Nicolaus Analyst forecast on OCS
Annabel Samimy
Stifel Nicolaus
Stifel Nicolaus
$50→$40
Buy
45.67%
Upside
Reiterated
06/01/26
Oculis price target lowered to $40 from $50 at StifelOculis price target lowered to $40 from $50 at Stifel
Needham Analyst forecast on OCS
Serge Belanger
Needham
Needham
$46→$38
Buy
38.38%
Upside
Reiterated
06/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT), Oculis Holding (NASDAQ: OCS) and Cogent Biosciences (NASDAQ: COGT)
LifeSci Capital Analyst forecast on OCS
Patrick Dolezal
LifeSci Capital
LifeSci Capital
$65→$45
Buy
63.87%
Upside
Reiterated
06/01/26
Oculis Maintained at Buy as Analyst Lowers Price Target to $45, Refocuses on Optic Neuritis Opportunity
H.C. Wainwright Analyst forecast on OCS
Yi Chen
H.C. Wainwright
H.C. Wainwright
$47→$26
Buy
-5.32%
Downside
Reiterated
06/01/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Robert W. Baird Analyst forecast on OCS
Colleen M. Kusy
Robert W. Baird
Robert W. Baird
$49→$38
Buy
38.38%
Upside
Reiterated
06/01/26
Oculis price target lowered to $38 from $49 at BairdOculis price target lowered to $38 from $49 at Baird
Chardan Capital Analyst forecast on OCS
Daniil Gataulin
Chardan Capital
Chardan Capital
$53
Buy
93.01%
Upside
Reiterated
05/12/26
Oculis Holding (OCS) Gets a Buy from Chardan Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Oculis Holding

3 Months
Yi ChenH.C. Wainwright
Success Rate
13/22 ratings generated profit
59%
Average Return
+1.34%
Copying Yi Chen's trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +1.34% per trade.
1 Year
Colleen M. KusyRobert W. Baird
Success Rate
10/13 ratings generated profit
77%
Average Return
+30.98%
Copying Colleen M. Kusy's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +30.98% per trade.
2 Years
Colleen M. KusyRobert W. Baird
Success Rate
10/13 ratings generated profit
77%
Average Return
+55.95%
Copying Colleen M. Kusy's trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +55.95% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OCS Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
6
6
5
13
23
Buy
0
2
4
8
6
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
8
9
21
29
In the current month, OCS has received 29 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OCS average Analyst price target in the past 3 months is 38.30.
Each month's total comprises the sum of three months' worth of ratings.

OCS Financial Forecast

OCS Earnings Forecast

Next quarter’s earnings estimate for OCS is -$0.50 with a range of -$0.57 to -$0.33. The previous quarter’s EPS was -$0.62. OCS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year OCS has Performed in-line its overall industry.
Next quarter’s earnings estimate for OCS is -$0.50 with a range of -$0.57 to -$0.33. The previous quarter’s EPS was -$0.62. OCS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year OCS has Performed in-line its overall industry.
No data currently available

OCS Sales Forecast

Next quarter’s sales forecast for OCS is $200.25K with a range of $0.00 to $380.21K. The previous quarter’s sales results were $0.00. OCS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year OCS has Performed in-line its overall industry.
Next quarter’s sales forecast for OCS is $200.25K with a range of $0.00 to $380.21K. The previous quarter’s sales results were $0.00. OCS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year OCS has Performed in-line its overall industry.

OCS Stock Forecast FAQ

What is OCS’s average 12-month price target, according to analysts?
Based on analyst ratings, Oculis Holding Ag’s 12-month average price target is 38.30.
    What is OCS’s upside potential, based on the analysts’ average price target?
    Oculis Holding Ag has 39.48% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is OCS a Buy, Sell or Hold?
          Oculis Holding Ag has a consensus rating of Strong Buy which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Oculis Holding Ag’s price target?
            The average price target for Oculis Holding Ag is 38.30. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $53.00 ,the lowest forecast is $23.00. The average price target represents 39.48% Increase from the current price of $27.46.
              What do analysts say about Oculis Holding Ag?
              Oculis Holding Ag’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of OCS?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.